Immunoreactivity of MIC2 (CD99) in Acute Myelogenous Leukemia and Related Diseases

[1]  R. Warnke,et al.  MIC2, TdT, bcl-2, and CD34 expression in paraffin-embedded high-grade lymphoma/acute lymphoblastic leukemia distinguishes between distinct clinicopathologic entities. , 1997, Human pathology.

[2]  R. Neiman,et al.  013 (CD99) positivity in hematologic proliferations correlates with TdT positivity. , 1997, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[3]  N. Weidner,et al.  Immunohistochemical Profile of Monoclonal Antibody 013: Antibody That Recognizes Glycoprotein p30/32MIC2 and is Useful in Diagnosing Ewing's Sarcoma and Peripheral Neuroepithelioma , 1994, The American journal of surgical pathology.

[4]  M. Link,et al.  MIC2 analysis in pediatric lymphomas and leukemias. , 1994, Human pathology.

[5]  F. Askin,et al.  Ewing's sarcoma--routine diagnostic utilization of MIC2 analysis: a Pediatric Oncology Group/Children's Cancer Group Intergroup Study. , 1994, Human pathology.

[6]  D Rampling,et al.  Immunocytochemical study of 12E7 in small round‐cell tumours of childhood: an assessment of its sensitivity and specificity , 1993, Histopathology.

[7]  A. Huvos,et al.  Comparison of Cell Surface Antigen HBA71 (p30/32MIC2), Neuron-Specific Enolase, and Vimentin in the Immunohistochemical Analysis of Ewing's Sarcoma of Bone , 1992, The American journal of surgical pathology.

[8]  S. Cole,et al.  The E2 antigen, a 32 kd glycoprotein involved in T‐cell adhesion processes, is the MIC2 gene product. , 1989, The EMBO journal.

[9]  G. de Rossi,et al.  Terminal transferase positive acute myeloid leukemia: Immunophenotypic characterization and response to induction therapy , 1989, Hematological oncology.

[10]  E. Fellinger,et al.  Characterization of a human endocrine tissue and tumor-associated Ewing's sarcoma antigen. , 1988, Cancer research.

[11]  D. Catovsky,et al.  Terminal deoxynucleotidyl transferase positive acute myeloid leukaemia: an association with immature myeloblastic leukaemia , 1988, British journal of haematology.

[12]  J. Manning,et al.  Granulocytic sarcoma in nonleukemic patients , 1986, Cancer.

[13]  M. González,et al.  TdT activity in acute myeloid leukemias defined by monoclonal antibodies , 1986, American journal of hematology.

[14]  H. Drexler,et al.  Incidence of TdT positivity in cases of leukemia and lymphoma. , 1986, Acta haematologica.

[15]  R. Warnke,et al.  A human thymus-leukemia antigen defined by hybridoma monoclonal antibodies. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[16]  H. Drexler,et al.  Terminal deoxynucleotidyl transferase (TdT) expression in acute myeloid leukemia. , 1993, Leukemia.

[17]  P. Deangelis,et al.  Biochemical and genetic characterization of the HBA71 Ewing's sarcoma cell surface antigen. , 1991, Cancer research.

[18]  P. Steinherz,et al.  Granulocytic sarcoma of the clavicle. , 1982, The American journal of pediatric hematology/oncology.